Book written in french
Hematology and transfusions have changed dramatically from a medical standpoint, with the development of new therapeutic tools (for transfusions or transfusion-related), new diagnostic methods (for patients who require a transfusion or whose treatment calls for a transfusion) and in terms of their organization with the reorganization of the French transfusion system (as a result of the contaminated blood scandal).
The two disciplines have fed into each other, with the French blood transfusion system now highly professional, the emphasis being on quality management, medicalisation of prescriptions, modernization of the organizations and the need for research and training.
Hematology has used this progress to improve the way in which blood products are used and how their safety is ensured. Hematology prescriptions are on the increase: the quantity of products transfused has increased by 10% over 3 years, and the increase in life expectancy coupled with treatment breakthroughs means that this trend looks set to continue.
Blood products (and therefore blood donors) will be required for the development of haematological products for at least the next ten years. Thus it is important that healthcare providers working in this sector have access to reference books.
This book describes the different aspects of transfusion as applied by blood product prescribers. The aim is to contribute to the interface between the disciplines of transfusion and haematology.
Obtaining and prescribing labile blood products: Donations – Biological qualification - Preparation – Prescribing and ordering - Distribution and delivery
Transfusion depending on blood product: red blood cells - Platelets - Plasma – Granulocyte concentrates – Cell therapy products
Transfusion as a function of age:
Neonates – Children - Elderly – End of life blood disorders
Transfusion for red blood cell disorders: Thalassemia syndrome - Drepanocytosis – Auto-immune hemolytic anemia
Transfusions in oncology-hematology: transfusion as an adjunct to chemotherapy - Indications and rules for using concentrates – Hematopoietic stem cell transplants
- Myelodysplasic syndromes – Post-transfusion graft versus host disease – Extracorporeal photochemotherapy – Monitoring patients after a transfusion
The risks of transfusion: Risk of infection - Cytomegalovirus – Non-infectious risks – Patient information
- Jehovah's witnesses
New blood: Placenta stem cell graft - Ex vivo expansion of hematopoietic cells for transplant – Outlook for stem cell transfusions – Storing blood
for donor, for recipient – Managing adverse reactions and serious events – Blood legislation
Blood derived medicines: Constitutional coagulation factor deficiency – Intravenous immunoglobulins - Safety
Book written in french